Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

Insurance Stocks Moving In Thursday's Intraday Session

According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.

Benzinga

This Weedmaps Analyst Sees These 'Tailwinds' For Cannabis Tech Provider After Q1 Earnings

Cannabis tech provider WM Technology Inc. (NASDAQ: MAPS), more commonly known as Weedmaps,

Benzinga

Trimble Shares Drop On FY22 Outlook Cut, Q1 Earnings Beat

Trimble Inc (NASDAQ:TRMB) reported first-quarter FY22 revenue growth of 12% year-on-year to $993.7 million, beating the consensus of $968.2 million. Annualized recurring revenue was $1.47 billion, up 12% Y/Y. Product revenue grew 15.2% Y/Y to $621.6 million. Service revenue was flattish at $161.1 million. Subscription revenue rose 14.2% Y/Y to $211 million. The…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Why Netflix Shares Are Diving

Shares of several gaming, streaming and social media companies, including Netflix Inc (NASDAQ: NFLX), are trading lower amid overall market weakness as traders continue to digest Wednesday's Fed rate hike announcement. An increase in yields has pressured tech and growth stocks.

Benzinga

What's Going On With Datadog Shares Today

Datadog, Inc (NASDAQ:DDOG) reported first-quarter FY22 revenue growth of 83% year-on-year to $363 million, beating the consensus of $337.8 million. As of March 31, Datadog had 2,250 customers with an ARR of $100,000 or more, increasing 60% Y/Y. The non-GAAP gross margin expanded 300 bps to 80%. The non-GAAP operating margin expanded by…

Benzinga

Why CommScope Shares Are Surging Today

CommScope Holding Company, Inc (NASDAQ:COMM) reported first-quarter FY22 net sales growth of 7.6% year-on-year to $2.23 billion, beating the consensus of $2.08 billion. Core net sales grew 10.3% Y/Y to $1.73 billion due to higher net sales in the Connectivity and Cable Solutions and Outdoor Wireless Networks segments. Connectivity and Cable Solutions' net…

Benzinga

Why BofA Double Downgrades Sprouts Farmers Market To Underperform

Sprouts Farmers Market Inc (NASDAQ: SFM) expects double-digit percentage cost inflation and price hikes to continue through 2022, according to BofA Securities.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

LTRN: First Quarter 2022 Financial and Operational Results

By John Vandermosten, CFA NASDAQ:LTRN READ THE FULL LTRN RESEARCH REPORT

Benzinga

Analyst Ratings for DISH Network

Over the past 3 months, 4 analysts have published their opinion on DISH Network (NASDAQ:DISH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Century Casinos Earnings Preview

Century Casinos (NASDAQ:CNTY) is set to give its latest quarterly earnings report on Friday, 2022-05-06. Here's what investors need to know before the announcement. Analysts estimate that Century Casinos will report an earnings per share (EPS) of $0.11.

Benzinga

Expert Ratings for Personalis

Personalis (NASDAQ:PSNL) has observed the following analyst ratings within the last quarter:

Benzinga

Dynavax's Adjuvant-Based Bivalent COVID-19 Vaccine Candidate Shows Encouraging Preclinical Action

Clover Biopharmaceuticals Ltd announced new promising data from a preclinical study on its bivalent vaccine candidate, which combines the trimeric spike antigens from the original SARS-CoV-2 strain and the omicron variant. Clover developed the SCB-2019 antigen, a stabilized trimeric form of the S-protein based on the original strain of the SARS-CoV-2 virus. It…

Benzinga

Mid-Day Market Update: U.S. Stocks Extend Losses; Dow Dips Over 1,100 Points

U.S. stocks extended losses midway through trading, with the Dow Jones dipping more than 1,100 points on Thursday.

Benzinga

Preview: Liberty Formula One Group's Earnings

Liberty Formula One Group (NASDAQ:FWONK) is set to give its latest quarterly earnings report on Friday, 2022-05-06. Here's what investors need to know before the announcement. Analysts estimate that Liberty Formula One Group will report an earnings per share (EPS) of $-0.21.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

A Preview Of Calumet Specialty's Earnings

Calumet Specialty (NASDAQ:CLMT) is set to give its latest quarterly earnings report on Friday, 2022-05-06. Here's what investors need to know before the announcement. Analysts estimate that Calumet Specialty will report an earnings per share (EPS) of $-0.52.

Benzinga

Novavax Seeks Approval For COVID-19 Shot Among Adolescents In Britain

Novavax Inc (NASDAQ:NVAX) filed an application with Britain's drugs regulator for the authorization of its COVID-19 vaccine among adolescents aged 12 and older. Britain had in February cleared the two-dose vaccine, Nuvaxovid, for use in adults. Novavax's submission includes data from a late-stage trial in the U.S., where the vaccine showed 80% efficacy among…

Benzinga

What 4 Analyst Ratings Have To Say About Morphic Holding

Over the past 3 months, 4 analysts have published their opinion on Morphic Holding (NASDAQ:MORF) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

57 Stocks Moving In Thursday's Mid-Day Session

Gainers

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Jazz Pharma, Sumitomo Pharma Ink Licensing Pact For Sleeping Disorder Candidate

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) has acquired development and commercialization rights in the U.S., Europe, and other territories for Sumitomo Pharma's investigational DSP-0187. DSP-0187 is a potent, highly selective oral orexin-2 receptor agonist with potential application for treating narcolepsy, idiopathic hypersomnia, and other sleep disorders. Jazz has designated this molecule JZP441. Sumitomo Pharma initiated a Phase…

Benzinga

Earnings Outlook For Athersys

Athersys (NASDAQ:ATHX) is set to give its latest quarterly earnings report on Friday, 2022-05-06. Here's what investors need to know before the announcement. Analysts estimate that Athersys will report an earnings per share (EPS) of $-0.10.

Benzinga

Capital Product Partners Earnings Preview

Capital Product Partners (NASDAQ:CPLP) is set to give its latest quarterly earnings report on Friday, 2022-05-06. Here's what investors need to know before the announcement. Analysts estimate that Capital Product Partners will report an earnings per share (EPS) of $0.95.

Benzinga

Wells Fargo Maintains Overweight Rating for Morphic Holding: Here's What You Need To Know

Wells Fargo has decided to maintain its Overweight rating of Morphic Holding (NASDAQ:MORF) and lower its price target from $81.00 to $79.00. Shares of Morphic Holding are trading down 3.76% over the last 24 hours, at $33.25 per share.

Benzinga

Preview: Ruth's Hospitality Group's Earnings

Ruth's Hospitality Group (NASDAQ:RUTH) is set to give its latest quarterly earnings report on Friday, 2022-05-06. Here's what investors need to know before the announcement. Analysts estimate that Ruth's Hospitality Group will report an earnings per share (EPS) of $0.30.

Benzinga

What 6 Analyst Ratings Have To Say About Hostess Brands

Hostess Brands (NASDAQ:TWNK) has observed the following analyst ratings within the last quarter:

Benzinga

Raymond James Maintains Outperform Rating for Upland Software: Here's What You Need To Know

Raymond James has decided to maintain its Outperform rating of Upland Software (NASDAQ:UPLD) and lower its price target from $30.00 to $24.00. Shares of Upland Software are trading down 10.11% over the last 24 hours, at $13.91 per share.

1 … 597 598 599 600

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Jazz Pharmaceuticals plc

44 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.